Eli Lilly stock has recovered nicely from a late November 2016 ... Let's look at several trends from when LLY stock bottomed at $65 per share last November. Please do not confuse these factors with competitive drug pricing or …
Indianapolis, IN-based Eli Lilly and Company LLY, is a global healthcare company which enjoys presence across a wide range of therapeutic areas including neuroscience, oncology, endocrinology, immunology and cardiovascular which are …
Cascadian Therapeutics Inc. (CASC) is all set to implement a 1-for-6 reverse stock split on November 29 ... Shares of Eli Lilly & Co. (LLY) were down 10% on Wednesday, following the failure of its phase III study of Solanezumab in people …
Shares of Eli Lilly and Co (NYSE:LLY) plunged to seven-month lows this afternoon ... Last month, his tweet targeting high-flying Ariad Pharmaceuticals caused the company’s stock to plummet 14% in a matter of minutes. We warned …
The post Insider Trading Activity Eli Lilly and Company (NYSE:LLY) – Major Shareholder Sold 220,000 shares of …
Usually when a portfolio manager eliminates a position, either the thesis on the stock has totally broken down or ... Here are the stocks that recently were added to the Piper Jaffray Model Portfolio. Concho Resources Inc. (NYSE: CXO) …
From StockNews.com: Eli Lilly and Co (NYSE:LLY) will acquire CoLucid Pharmaceuticals, a maker of a cutting edge migraine headache treatment, for $960 million, the two companies announced this morning. The $46.50 per share …
SunTrust’s top pharmaceutical stocks to buy for 2015 include Merck & Co. Inc. (NYSE: MRK), Bristol-Myers Squibb Co. (NYSE: BMY), Eli Lilly & Co. (NYSE: LLY), Shire PLC (NASDAQ ... The SunTrust price target for the stock is $80. The …